New Dems Urge House Leadership to Move Bipartisan Drug Pricing Bills
WASHINGTON – Members of the New Democrat Coalition’s Healthcare Task Force asked the House leadership on Wednesday to hold a floor vote on drug pricing bills with bipartisan support as early as next week.
The request was made in a letter sent to House Speaker Nancy Pelosi, Majority Leader Steny Hoyer, Majority Whip Jim Clyburn, and Assistant Leader Ben Ray Luján.
In it, Representatives Angie Craig, of Minnesota, Kurt Schrader, of Oregon, Kim Schrier, of Washington, and Greg Stanton, of Arizona, say while they support efforts to stabilize and expand on the Affordable Care Act, their constituents are demanding action be taken soon to curb the rising costs of prescription drugs.
The task force members ask the House leaders to consider bringing the bipartisan drug pricing bills included in H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act, to the floor in a standalone package for a vote next week when other healthcare measures are expected to be considered.
“Each of the drug pricing bills in H.R. 987 had bipartisan support when introduced, as well as through the Committee process,” the representatives say.
“While we were optimistic our Republican colleagues would support commonsense fixes to strengthen the ACA, this comprehensive package was passed out of the House with only Democratic support,” they continue. “Consequently, our colleagues in the Senate have yet to vote on these noncontroversial drug pricing measures and send them to the President for enactment.”
The representatives note that at least three bills in the package would have an immediate moderating effect on prescription drug prices.
These include H.R. 965, the CREATES Act, introduced by Representative David Cicilline, of Rhode Island; H.R. 938, the BLOCKING Act, introduced by Representative Kurt Schrader, of Oregon; and H.R. 1499, the Protecting Consumer Access to Generic Drugs Act, introduced by Representative Bobby Rush, of Illinois.
The New Democrat Coalition members closed by reminding the House leaders and their colleagues across the aisle that “the rising cost of prescription drugs remains of paramount concern to all members, irrespective of political affiliation.
“There are families in every single congressional district struggling to pay for their prescription drugs. As such, this challenge calls for a unified approach. Respectfully, we urge leadership to bring these bipartisan measures to the floor and, in doing so, reiterate our commitment to tackling the rising cost of prescription drugs in a bipartisan manner before the August recess,” the members say.
In The News
HAMBURG, Germany — Researchers around the world hail Germany for its robust health care system: universal coverage, plentiful primary care, low drug prices and minimal out-of-pocket costs for residents. Unlike in the U.S., the prospect of a large medical bill doesn’t stand in the way of... Read More
WASHINGTON - Accustomed as they are to believing government can do a great deal of good for a great many, serious Democrats have grown increasingly concerned over the potential long-term ramifications of Medicare for all proposals. While it's easy -- and perhaps hopeful -- to view... Read More
WASHINGTON - A quartet of House Democrats want to see Medicare Part B coverage expanded to include routine vision benefits. Right now, Medicare only covers surgery and screenings for people who are at a high risk of getting cataracts and glaucoma, but it but does not... Read More
WASHINGTON - Rep. Max Rose hosted a roundtable for seniors in Brooklyn, N.Y. on Saturday to bring them up to speed on his proposal to lower prescription drug prices. Rose met with members of AARP Bay Ridge Chapter 3630 to talk about his support of the... Read More
WASHINGTON - Rep. Abigail Spanberger, D-Va., wants $10 billion allocated to the National Institutes of Health over the next 10 years as a catalyst for medical cures and scientific breakthroughs. The Biomedical Innovation Expansion Act introduced last week by Spanberger and Reps. Mikie Sherrill, D-N.J., and... Read More
The governors of five northeastern states came together for a summit on Thursday to discuss the outlines of a joint regional approach to cannabis and vaping policies. "This issue is complicated, controversial and consequential. It is probably one of the most challenging I've had to address... Read More